Valuation: Edwards Lifesciences Corporation

Market Cap 51.75B 44.33B 41.48B 37.97B 71.26B 4,952B 72.2B 490B 191B 2,488B 194B 190B 8,228B P/E 2026 *
35.5x
P/E 2027 * 27.2x
Enterprise Value 48.12B 41.22B 38.57B 35.31B 66.26B 4,604B 67.14B 456B 178B 2,313B 181B 177B 7,651B EV / Sales 2026 *
7.12x
EV / Sales 2027 * 6.27x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.04%
1 week-1.98%
Current month+4.32%
1 month+6.42%
3 months+4.67%
6 months+12.55%
Current year+5.33%
1 week 88.79
Extreme 88.79
93.25
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
8/11/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
7/30/26 Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%-1.98%+9.73%+18.19% 51.75B
+0.27%+6.97%+25.86%+19.39% 233B
+1.36%+8.10%+3.33%-12.35% 154B
+1.16%-3.98%-20.44%+31.92% 134B
+2.03%-2.82%-52.56%-0.08% 73B
+0.98%+2.26%-16.22%-12.49% 52.24B
+1.73%+7.05%+30.72%+35.16% 44.91B
+1.49%-0.36%+35.91%+53.26% 40.35B
+1.03%+1.53%-0.53%+8.54% 33.8B
+1.35%+3.15%-21.18%+42.40% 33.4B
Average +1.14%+1.90%-0.54%+18.39% 84.98B
Weighted average by Cap. +0.99%+3.01%+2.02%+14.83%

Financials

2026 *2027 *
Net sales 6.76B 5.79B 5.42B 4.96B 9.31B 647B 9.43B 64.01B 24.96B 325B 25.38B 24.83B 1,075B 7.43B 6.36B 5.95B 5.45B 10.23B 711B 10.36B 70.35B 27.43B 357B 27.9B 27.29B 1,181B
Net income 1.44B 1.23B 1.15B 1.05B 1.98B 137B 2B 13.59B 5.3B 68.98B 5.39B 5.27B 228B 1.9B 1.62B 1.52B 1.39B 2.61B 181B 2.65B 17.96B 7B 91.16B 7.12B 6.97B 302B
Net Debt -3.63B -3.11B -2.91B -2.66B -5B -347B -5.07B -34.38B -13.41B -175B -13.63B -13.34B -577B -5.19B -4.45B -4.16B -3.81B -7.15B -497B -7.25B -49.19B -19.18B -250B -19.51B -19.08B -826B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-21 $89.79 -0.04% 2,819,775
26-08-20 $89.83 -2.65% 2,638,021
26-08-19 $92.28 +1.43% 3,406,151
26-08-18 $90.98 +0.19% 2,762,349
26-08-17 $90.81 -0.86% 2,246,351
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.79USD
Average target price
100.96USD
Spread / Average Target
+12.44%

Quarterly revenue - Rate of surprise